Scientists identify new genetic causes linked to abnormal pregnancies and miscarriages

November 20, 2018, McGill University Health Centre
The researchers from left to right: Jacek Majewski, Rima Slim,Teruko Taketo, (front row) and ZhaoJia Ge and Ngoc Minh Phuong Nguyen (back row). Credit: McGill University Health Centre

A team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University have identified three genes responsible for recurrent molar pregnancies, a rare complication that occurs when a non-viable pregnancy with no embryo implants in the uterus. The results of this study could have important implications, since until now very little is known about the genetic causes of all forms of fetal loss. Their study has recently been published in The American Journal of Human Genetics.

In Quebec, molar occurs in about one in every 600 pregnancies, and half of these are characterized by a total absence of maternal chromosomes. Due to an imbalance in the number of chromosomes supplied from the mother and the father, the placental tissue grows abnormally and forms a tumour, leading to a malignant cancer in approximately 15 to 20 per cent of cases. Molar pregnancy is the most common form of all placental diseases (or trophoblastic diseases).

"Our findings add three new genes to the list of mutations leading to fetal loss and will allow for more DNA testing for patients in order to prevent the recurrence of molar pregnancies and provide better genetic counselling and management for couples," says lead study author Dr. Rima Slim, who is a researcher in the Child Health and Human Development (CHHD) Program at the RI-MUHC and an associate professor of Human Genetics and Obstetrics and Gynecology at McGill University.

However, clinicians and scientists still do not fully understand why a molar pregnancy occurs.

"Human pregnancies with no embryos have fascinated and puzzled scientists in all civilizations since the time of Hippocrates," says Dr. Slim, who has been working on molar pregnancies for more than 15 yeras. "Our findings uncover, for the first time, a mechanism for the genesis of this abnormality and link the causal factors involved in recurrent molar pregnancies, miscarriages, and male and female infertility to mutations in three genes."

Short video showing a oocyte (left) that is losing its chromosomes (in red). Credit: Rima Rozen's laboratory, Research Institute of the McGill University Health Centre
Three new genes identifiedIn their new study, Dr. Slim and colleagues identified mutations in MEI1, TOP6BL/C11orf80, and REC114 in patients who had molar pregnancies without maternal chromosomes and recurrent miscarriages. They further investigated the impact of the Mei1 mutation in a to understand how the maternal chromosomes are lost.

The objective was to see whether Mei1-deficient mice produce oocytes (early eggs or ova) lacking maternal chromosomes, and to find out when and how these oocytes lose their chromosomes—questions that have remained unanswered since molar pregnancies were first described in 1977.

The researchers followed the development of oocytes from mice in which the Mei1 gene had been deleted. In some of these mice, the absence of the gene caused conceptions with an abnormal number of maternal chromosomes, and the conceptions did not survive implantation in the uterus, leading to infertility. In others, some oocytes lost all their chromosomes before fertilization and were empty; fertilization of these eggs was still possible.

Bringing together expertise in next-generation sequencing and mouse models

This discovery was made possible thanks to collaboration with Dr. Jacek Majewski's team at the McGill University and Génome Québec Innovation Centre, who oversaw sequencing of 68 patients and helped Dr. Slim's team to identify three novel genes in eight patients. Research partners from the Registre des maladies trophoblastiques du Québec and from India, Turkey and the United States referred patients for the study.

A zygote (or fertilized egg) containing only paternal chromosomes (in blue) while all maternal chromosomes (in cyan) are in the polar body. Credit: Rima Slim's laboratory, Research Institute of the McGill University Health Centre
"The mouse model was very important in producing new understanding of how these abnormal pregnancies occur without maternal ," says the study's co-author Dr. Teruko Taketo, a researcher in the CHHD Program of the RI-MUHC, who enabled the team to look at the development of oocytes of Mei1-deficient mice as they matured in vitro.

A partnership to help patients

Since 2010, Professor Slim has been collaborating on the identification of genetic causes of molar pregnancies with Dr. Philipe Sauthier, gyneco-oncologist at the University Hospital of Montreal (CHUM), who founded the Quebec Trophoblastic Disease Network (RMTQ).

"The painful experience of a fetal loss associated with the of an abnormal pregnancy is often destabilizing and stressful for women," says Magali Breguet, nurse coordinator of the RMTQ. "This collaboration is a positive step forward for women who must undergo several months of medical monitoring and also live with the anxiety that their next pregnancy may also be a ."

Explore further: Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

More information: Ngoc Minh Phuong Nguyen et al, Causative Mutations and Mechanism of Androgenetic Hydatidiform Moles, The American Journal of Human Genetics (2018). DOI: 10.1016/j.ajhg.2018.10.007

Related Stories

Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

November 14, 2018
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta. Researchers from the Wellcome Sanger Institute, Newcastle ...

At least one year between pregnancies reduces risks for mother and baby

October 29, 2018
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.

Inducing labor at 39 weeks may benefit pregnant women and their babies

October 17, 2018
As the prevalence of maternal and fetal complications increases with advancing pregnancy beyond 39 weeks, induction of labor at 39 weeks has been proposed as a means to ensure optimal maternal and newborn health.

Surveillance is sufficient for women following molar pregnancy: study

November 28, 2011
Six months following molar pregnancies, women who have high (although decreasing) human chorionic gonadotropin (hCG) concentrations can be treated with chemotherapy. A study published Online First by The Lancet shows that ...

Gene mutation may be linked to unexplained female infertility

March 21, 2017
Researchers at Baylor College of Medicine, Texas Children's Hospital and Rice University have uncovered a gene mutation that may provide answers to unexplained female infertility. The study appears in Scientific Reports, ...

Recommended for you

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Scientists identify method to study resilience to pain

December 14, 2018
Scientists at the Yale School of Medicine and Veterans Affairs Connecticut Healthcare System have successfully demonstrated that it is possible to pinpoint genes that contribute to inter-individual differences in pain.

CRISPR joins battle of the bulge, fights obesity without edits to genome

December 13, 2018
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA. In a paper published Dec. 13, 2018, in the journal Science, UC San Francisco researchers describe how a modified version of CRISPR was used ...

Noncoding mutations contribute to autism risk

December 13, 2018
A whole-genome sequencing study of nearly 2,000 families has implicated mutations in 'promoter regions' of the genome—regions that precede the start of a gene—in autism. The study, which appears in the December 14 issue ...

New method for studying ALS more effectively

December 13, 2018
The neurodegenerative disease ALS causes motor neuron death and paralysis. However, long before the cells die, they lose contact with muscles as their axons atrophy. Researchers at Karolinska Institutet in Sweden have now ...

Paternal grandfather's high access to food may indicate higher mortality risk in grandsons

December 12, 2018
A paternal grandfather's access to food during his childhood is associated with mortality risk, especially cancer mortality, in his grandson, shows a large three-generational study from Stockholm University. The reason might ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.